In the ARROS-1 trial, 48% of patients achieved partial responses to NVL-520, with responses seen across all dose levels and in heavily pre-treated patients. The treatment also showed promise for brain metastases, with three out of three patients experiencing measurable response or no emergence of new metastases.
Researchers have found a drug that targets the key, cancer-causing gene MYC has been able to inhibit its function safely and effectively. Eight out of 12 patients showed stabilisation of disease after treatment with OMO-103, with one patient experiencing a reduction in tumour-derived DNA circulating in the blood stream.
Researchers from the University of Connecticut found that both delta-8 and delta-9 THC produce similar effects in mice, including lethargy and catalepsy. The study suggests that delta-8 THC interacts with the same receptors as delta-9 THC and can lead to desensitization and withdrawal-like symptoms.
A recent study analyzed the records of over 33,000 dementia patients in Wales and found that those closest to their diagnosis were taking an average of three or more medications. This suggests a possible link between polypharmacy and the development of dementia.
Researchers aim to shift policing focus from law enforcement to building strong communities through situational policing. The approach considers connections within the community and collaboratively builds resources.
A Phase I/II study found tofacitinib effective in improving skin and organ issues in systemic sclerosis patients. The drug was well-tolerated, with minimal impact on T-cells, suggesting potential repurposing for treatment.
A Swedish cohort study found that direct oral anticoagulants (DOACs) were associated with a lower risk of kidney function decline or kidney failure compared to vitamin K antagonists (VKA). DOACs also showed a lower risk of acute kidney injury.
A study by the BMJ found that less than a third of FDA regulatory actions are backed by published research findings or public assessments. The researchers analyzed drug safety signals from 2008 to 2019 and found that most regulatory actions were based on changes to drug labeling, with only about 30% corroborated by relevant studies.
A clinical trial of email alerts from pharmacists to doctors and other practitioners found no reduction in risky opioid prescribing, highlighting the need for rigorous testing of policies aimed at making opioid prescribing safer. The study tested behavioral science techniques to encourage safer prescribing practices.
A new study from North Carolina State University reveals that law enforcement is not uniformly recognizing and respecting the legal protections in place to support harm reduction programs. Despite these protections, more than half of survey participants reported negative experiences with law enforcement, including confiscation of suppl...
Researchers from Xi'an Jiaotong-Liverpool University found that brain stimulation combined with a nose spray containing nanoparticles can improve recovery after ischemic stroke. The treatment increased cognitive and motor functions, and weighed more quickly than those treated with TMS alone.
Researchers at UMC Utrecht will investigate how intestinal microbiota impacts cancer immunotherapy and therapy side effects. The project aims to develop microbiota-targeted therapies to improve ICI treatment effectiveness and reduce severe inflammation.
A new biologic drug has been found to be highly effective in reducing the signs and symptoms of moderate-to-severe eczema in infants and young children. The study showed that more than half of treated children experienced a 75% reduction in eczema symptoms, leading to improved sleep and increased ability to lead normal lives.
A new analysis reveals that mandatory prescription drug monitoring programs (PDMPs) do not significantly impact retail opioid sales across eight commonly prescribed opioids. The findings suggest that PDMP implementation is best considered as part of a broader policy response to the opioid crisis.
A systematic review and meta-analysis of observational studies found a moderate association between antipsychotic use and an increased risk of breast cancer, estimated at over 30%. The study highlights the importance of risk-benefit assessment of antipsychotic prescription in high-risk patients.
A study by Massachusetts General Hospital researchers found that fentanyl stops breathing before noticeable changes occur, leading to a high risk of death when used illicitly. The discovery could enable safer opioid administration through EEG monitoring.
A clinical trial found that long-term use of evolocumab led to further reductions in cardiovascular events compared to shorter treatment. Participants who received evolocumab for over 5 years had lower risk of cardiovascular death, myocardial infarction, stroke, and hospitalization.
A national survey of US psychiatrists found discrepancies between their perceptions of certain psychoactive drugs' safety and therapeutic value and how they are categorized under the Controlled Substances Act. Psychiatrists rated psilocybin as having low misuse potential and high therapeutic potential, but it is a Schedule I drug with ...
A tiny sensor can detect lithium levels from sweat on a fingertip in 30 seconds, providing a non-invasive alternative to blood tests. The sensor, developed by researchers, has the potential to improve medication adherence and patient care.
A new drug, TB31F, has been shown to block the transmission of malaria parasites by mosquitoes, preventing further malaria cases. The antibody was tested in humans and found safe with no important side effects.
Researchers at UNH will develop and test social assistive robots to aid in the care of individuals with Alzheimer’s disease and related dementia in their own homes. The robots will be equipped with smart home devices, artificial intelligence, and wearables to track patients' activity levels and health management.
A cohort study found that reinfection rates are low after successful hepatitis C virus (HCV) treatment in people who inject drugs, suggesting a benefit of treatment in this population. The risk for reinfection was highest among those with ongoing injecting drug use and needle sharing.
A study found that a majority of online pharmacies selling imatinib, a chronic myeloid leukemia therapy, are uncertified and operate unsafely. Patients may face risks of nonadherence, treatment failures, and adverse events if they use these pharmacies.
National data indicate that expanded access to methadone treatment during the COVID-19 pandemic did not lead to increased harms, but rather declined percentage of overdose deaths involving methadone. This evidence supports expanding take-home treatment for opioid use disorder.
A multicenter study found that traditional Chinese medicine Yupingfeng was as effective as allopathic drugs in treating recurrent respiratory tract infections in children. The study showed a substantially greater reduction in RRTI events and similar safety profiles across all three groups.
A study by ETH Zurich researchers shows a sharp increase in opioid poisoning cases and sales in Switzerland between 2000 and 2019, with oxycodone being the second most common cause. The rise is similar to that seen in other European countries, but per capita sales are higher in Switzerland.
A study by WVU researcher Ednilson Bernardes found that supplier pool pressure contributed to the oversupply of prescription opioids like oxycodone and hydrocodone. The researchers analyzed transactions from 2006-2012, revealing that over 90% of supply came from just three generics manufacturers.
Researchers at Purdue University have developed edible fluorescent silk tags with QR codes to verify whiskey authenticity, which can be activated with a smartphone scan. The technology has the potential to combat fake medications and address counterfeiting issues worldwide.
Physicians recognize benzodiazepine dependence as a significant contributor to the opioid crisis, coined a new term CPBD. Long-term treatment can lead to severe withdrawal symptoms and recurrence of underlying anxiety and insomnia.
A global black market for COVID-19 antiviral drugs is emerging, putting patients' health in jeopardy due to unequal distribution and substandard products. The investigation found that patients are buying pills online without medical supervision, increasing the risk of birth defects and viral resistance.
Research found that men taking abiraterone or enzalutamide plus hormone therapy had a higher risk of metabolic and cardiovascular issues than those undergoing hormone therapy alone. This increased risk was observed in patients with Medicare health insurance, who were significantly older than those in clinical trials.
A new study found that Medicare spent $1.2 billion on 36 drugs with no confirmed clinical benefits, mainly for cancer-related indications. The study suggests reforming the FDA's accelerated approval program to reduce waste and ensure patients receive effective treatments.
A new clinical decision support software platform reduces harm due to medication errors in the OR by more than 95%. Clinicians using the system work with greater efficiency and provide better care, with improved blood pressure control and accurate pain medication adjustments.
A global study found a combination of two drugs dramatically reduces the chances of suffering an asthma attack. The combination of albuterol and budesonide lowers the number of sudden episodes of shortness of breath, wheezing, and coughing in patients.
Less than half of Americans with opioid use disorder received a potentially lifesaving medication over a five-year period. Buprenorphine, which reduces overdose risk, was prescribed even less often for those with polysubstance use disorder, highlighting the underutilization of this effective treatment.
A study by researchers at the University of Pennsylvania School of Medicine found that mailing opioid disposal kits doubled the rate of safe disposal among patients who received them. The kits were provided to 235 patients after orthopedic or urologic procedures and resulted in the safe disposal of 480 unused tablets.
Researchers developed a deep learning-based model to predict drug-drug interactions using gene expression data. The DeSIDE-DDI model can identify potentially dangerous pairs and act as a drug safety monitoring system, helping establish the correct usage of drugs in the development phase.
A study found that regular pharmacist visits reduced medicine-related problems by 60% and improved cognition scores. The research highlights the need for personalized pharmaceutical support within the aged-care sector to prevent harm from medicines.
A new study found that opioid-related mortality rates in Ontario, Canada, have shifted downward to peak in the mid-30s among males and females. The study analyzed high-frequency data from 2003 to 2020 and hypothesizes that opioid-related mortality among younger adults will continue to grow.
A Canadian study of over 12,000 hospital admissions found that updated product label changes did not reduce rates of accidental acetaminophen overdose. The study suggests additional measures are needed to prevent these episodes beyond just labeling changes.
A new study found that Black kidney transplant recipients exhibit a faster clearance rate of tacrolimus, an immunosuppressive drug. The study suggests that considering both sex and race when dosing tacrolimus may reduce adverse effects and enhance transplant outcomes.
Researchers at Tokyo University of Science discovered that disulfiram inhibits FROUNT protein and chemokine signaling pathways, reducing anxiety levels in mice. The study suggests a potential breakthrough anti-anxiety medication with safe and effective treatment for elderly patients suffering from anxiety and insomnia.
Researchers developed innovative smart sensors to test new vaccines, revealing significant discrepancies between subjective self-reports and objective measurements. The study found that side effects escalate over the first 48 hours and then stabilize, with parameters returning to pre-vaccination levels.
A small study of 26 individuals with mild cognitive impairment found that taking SAGE-718 daily improved scores on a common cognitive test by an average of 2.3 points after one month. Participants also showed improvements in daily activities, such as using a computer and managing medications.
A new study shows that a potential treatment for Alzheimer's disease, sargramostim, improves cognitive function in people with Down syndrome and normal aging mice. The drug reverses learning and memory deficits, nerve cell loss, and brain abnormalities in mouse models of Down syndrome and aging.
A post-hoc subgroup analysis of the AFIRE trial found that reduced kidney function significantly influences bleeding events during antithrombotic therapy. Patients with healthy kidney function have a decreased risk of bleeding over time, while those with reduced kidney function remain at high risk.
A history-based screening for medication abortion was found to be both effective and safe in this study, with a total of 3,779 patients involved. The researchers used either in-person dispensing or mailing of medications, without the need for ultrasonography or pelvic examination.
A new study published in Frontiers in Oncology has shown that mRNA-based Covid-19 vaccines are well-tolerated by high-risk patients with impaired immunity. The trial enrolled 566 patients and found no evidence of increased adverse events or interference with treatment, reassuring vaccine-hesitant immunocompromised individuals.
The National Comprehensive Cancer Network has published new consensus recommendations to improve the safety and efficiency of research studies involving investigational drugs. The recommendations focus on seven areas, including pharmacy workflows and collaboration with sponsors.
The collaboration aims to accelerate addressing unmet needs in the neonatal population by applying quantitative modeling, biomarkers, and regulatory science. Patients and families will benefit from improved understanding of bronchopulmonary dysplasia and better patient enrollment for trials.
Fosfomycin, a long-dormant antibiotic, has been revived as a potential treatment for multidrug-resistant E. coli infections. The study involved 143 patients with invasive urinary tract infections and found effective results, offering an alternative to last-resort antibiotics.
Researchers found that 1% of US adults taking opioids are also prescribed benzodiazepines and other sedatives. This polypharmacy approach is linked to increased side effects and may pose dangers to vulnerable populations.
Researchers from Florida Atlantic University advise against prescribing ivermectin to treat or prevent COVID-19 due to the lack of reliable evidence. They emphasize the importance of relying on proven therapeutic innovations and vaccinations to combat the pandemic, citing the risks of unproven treatments like ivermectin.
Researchers found a significant increase in overdose deaths involving gabapentinoids and z-drugs between 2000 and 2018. The proportion of deaths increased by more than three-fold, coinciding with exponential prescription increases. Co-usage with opioids was common, with over 67% of overdose victims having both substances in their system.
A comprehensive genetic study found actionable pharmacogenomic variation affecting drugs in the Qatari population, highlighting diverse distribution of variants compared to other world populations. The study suggests potential implications for preemptive pharmacogenomic implementation in Qatar and beyond.
A new study by University of Chicago researchers found no evidence that LSD microdosing improves mood and cognitive function. However, the study did confirm that taking small doses of LSD is safe, with participants building a tolerance to the drug over time.
A recent study found that drug checking programs can reach people who would not access services otherwise, reducing overdoses and increasing HIV testing. The program also improved demand for other services like treatment for opioid use disorder.
A recent University at Buffalo-led study found that nearly 1 in 7 COVID patients in ICU experienced severe bleeding when given full-dose blood thinners. The research compared the safety and effectiveness of two blood clot treatment strategies, finding that a smaller dose was equally effective but carried less bleeding risk.
Researchers create plan for proactively developing drug cocktails against virus families, aiming to provide effective treatments in weeks, not months. The approach prioritizes combination therapy to reduce disease spread and limit viral adaptation.
A new study published in the Canadian Journal of Cardiology found that frail patients with atrial fibrillation are under-prescribed for direct oral anticoagulants (DOACs), a safer alternative to traditional warfarin treatment. Despite needing DOACs most, these patients are less likely to receive them than non-frail patients.